The purinergic signalling and inflammation in the pathogenesis and progression of diabetes: key factors and therapeutic targets
- PMID: 35648156
- DOI: 10.1007/s00011-022-01587-x
The purinergic signalling and inflammation in the pathogenesis and progression of diabetes: key factors and therapeutic targets
Abstract
Type 2 diabetes mellitus (T2DM) is an important chronic disease around the world, and according to the World Health Organization, it is the 9th principal cause of global death. This pathology is characterized by high levels of circulating glucose as a result of insulin resistance, and it is well stated that inflammation related to obesity is directly associated with the development of the disease. The purinergic signalling is involved in both pancreatic destruction, which impairs insulin secretion, and the cytokine production that favors insulin resistance in T2DM. In this review, the purinergic signalling aspects will be discussed, showing the impact of the enzymes, nucleotides, nucleosides, and receptors of this system and the cytokines that result in inflammation, in the development and progression of T2DM, besides, pointing the purinergic receptors as a possible therapeutic approach.
Keywords: Immune system; Inflammation; Purinergic signalling; T2DM.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β-Cell Dysfunction.Oxid Med Cell Longev. 2015;2015:181643. doi: 10.1155/2015/181643. Epub 2015 Jul 14. Oxid Med Cell Longev. 2015. PMID: 26257839 Free PMC article. Review.
-
Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus.J Cell Biochem. 2013 Mar;114(3):525-31. doi: 10.1002/jcb.24402. J Cell Biochem. 2013. PMID: 22991242 Review.
-
Cell- and tissue-specific epigenetic changes associated with chronic inflammation in insulin resistance and type 2 diabetes mellitus.Scand J Immunol. 2018 Dec;88(6):e12723. doi: 10.1111/sji.12723. Epub 2018 Nov 4. Scand J Immunol. 2018. PMID: 30589455 Review.
-
EP4 signalling is essential for controlling islet inflammation by causing a shift in macrophage polarization in obesity/type 2 diabetes.Diab Vasc Dis Res. 2020 Jul-Aug;17(4):1479164120945675. doi: 10.1177/1479164120945675. Diab Vasc Dis Res. 2020. PMID: 32722929 Free PMC article.
-
Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.Nat Rev Endocrinol. 2015 Apr;11(4):228-41. doi: 10.1038/nrendo.2015.10. Epub 2015 Feb 17. Nat Rev Endocrinol. 2015. PMID: 25687993 Review.
Cited by
-
Nonselective and A2a-Selective Inhibition of Adenosine Receptors Modulates Renal Perfusion and Excretion Depending on the Duration of Streptozotocin-Induced Diabetes in Rats.Pharmaceuticals (Basel). 2023 May 11;16(5):732. doi: 10.3390/ph16050732. Pharmaceuticals (Basel). 2023. PMID: 37242515 Free PMC article.
-
Association of Parity with Type 2 Diabetes Mellitus in Japan.Reprod Sci. 2025 Feb;32(2):366-381. doi: 10.1007/s43032-024-01752-z. Epub 2024 Dec 11. Reprod Sci. 2025. PMID: 39663299 Free PMC article.
-
Purines and purinergic receptors in primary tumors of the central nervous system.Purinergic Signal. 2025 Jun;21(3):429-446. doi: 10.1007/s11302-024-10053-8. Epub 2024 Oct 1. Purinergic Signal. 2025. PMID: 39352574 Free PMC article.
References
-
- Federation, International Diabetes. IDF DIABETES ATLAS. 9th ed. Bruxelas, Bélgica: International Diabetes Federation; 2019.
-
- Brown AE, Walker M. Genetics of insulin resistance and the metabolic syndrome. Curr Cardiol Rep. 2016;18:75. https://doi.org/10.1007/s11886-016-0755-4 . - DOI - PubMed - PMC
-
- Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res. 2005;36:197–209. https://doi.org/10.1016/j.arcmed.2005.01.003 . - DOI - PubMed
-
- Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet (London, England). 2017;389:2239–51. https://doi.org/10.1016/S0140-6736(17)30058-2 . - DOI
-
- Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105:141–50. https://doi.org/10.1016/j.diabres.2014.04.006 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical